Victory Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.5K Buy
26,921
+1,863
+7% +$3.14K ﹤0.01% 2324
2025
Q4
$41.8K Sell
25,058
-1,129
-4% -$1.95K ﹤0.01% 2345
2025
Q3
$44.3K Sell
26,187
-924
-3% -$1.09K ﹤0.01% 2353
2025
Q2
$24.6K Sell
27,111
-296
-1% -$176 ﹤0.01% 2430
2025
Q1
$12.4K Buy
27,407
+323
+1% +$189 ﹤0.01% 2447
2024
Q4
$13.6K Buy
27,084
+3,219
+13% +$2.36K ﹤0.01% 2462
2024
Q3
$21.6K Sell
23,865
-415
-2% -$385 ﹤0.01% 2436
2024
Q2
$24.2K Sell
24,280
-390
-2% -$431 ﹤0.01% 2415
2024
Q1
$36.5K Buy
24,670
+1,175
+5% +$1.33K ﹤0.01% 2398
2023
Q4
$25.6K Buy
23,495
+4,265
+22% +$4.67K ﹤0.01% 2495
2023
Q3
$22.7K Buy
19,230
+804
+4% +$1.09K ﹤0.01% 2441
2023
Q2
$26K Sell
18,426
-428
-2% -$591 ﹤0.01% 2434
2023
Q1
$28.3K Sell
18,854
-219
-1% -$306 ﹤0.01% 2486
2022
Q4
$22.3K Sell
19,073
-7
-0% -$9 ﹤0.01% 2505
2022
Q3
$22K Sell
19,080
-3,571
-16% -$5.24K ﹤0.01% 2622
2022
Q2
$36K Buy
22,651
+241
+1% +$318 ﹤0.01% 2580
2022
Q1
$27K Sell
22,410
-1,129
-5% -$1.75K ﹤0.01% 2632
2021
Q4
$58K Sell
23,539
-574
-2% -$1.34K ﹤0.01% 2632
2021
Q3
$61K Sell
24,113
-414
-2% -$1.06K ﹤0.01% 2672
2021
Q2
$70K Buy
24,527
+1,133
+5% +$2.93K ﹤0.01% 2642
2021
Q1
$55K Sell
23,394
-728
-3% -$1.75K ﹤0.01% 2662
2020
Q4
$42K Buy
24,122
+1,233
+5% +$1.72K ﹤0.01% 2468
2020
Q3
$21K Sell
22,889
-1,294
-5% -$1.14K ﹤0.01% 2433
2020
Q2
$21K Sell
24,183
-25,637
-51% -$22.6K ﹤0.01% 2443
2020
Q1
$42K Buy
+49,820
New +$49.6K ﹤0.01% 2839
2019
Q4
Sell
-25,867
Closed -$25K 2966
2019
Q3
$25K Buy
+25,867
New +$26.8K ﹤0.01% 2963

Other funds holding LCTX